|
FDA maintains that: “To be acceptable the data should meet certain fundamental elements
of quality whether collected or recorded electronically or on paper. Data
should be attributable, original, accurate, contemporaneous, and legible.
For example, attributable data can be traced to individuals responsible
for observing and recording the data.” (FDA
Guidance for Industry: Computerized Systems Used in Clinical Trials, April
1999) |